Publication: 3392

Genomic analysis of the CALGB 40603 (Alliance) neoadjuvant trial in TNBC identifies immune features associated with pathological complete response and event-free survival
      Google Scholar   
Citation:
Cancer Res vol 81 (4 Supplement) PD9-03
Meeting Instance:
SABCS 2020
Year:
2020
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
3313   3660  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Genentech  
Grants:
U10CA180821, U10CA180882, U24CA196171  
Corr. Author:
 
Authors:
                             
Networks:
KAISER, LAPS-MA036, LAPS-NC007, RI005   
Study
CALGB-40603
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: